Atlas Trials

Radical Cure (RC) With Tafenoquine or Primaquine After Semi-quantitative G6PD Testing: A Feasibility Study in Peru

Clinical trial NCT05361486 · COMPLETED

Trial details

NCT number
NCT05361486
Sponsor
Medicines for Malaria Venture
Status
COMPLETED
Study type
OBSERVATIONAL
Malaria, Vivax
Start date
2023-08-28
Primary completion
2024-12-31
Enrollment
187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.